Developer docs
API playgroundTry for free, no card

Search company profiles

Biocompare

Full company profile

uuid0009hqe

Namestring
Biocompare
Legal namestring
CompareNetworks, Inc.
Websiteurl
biocompare.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Biocompare is a B2B product comparison and buyer education platform for the life sciences industry, operated as a division of privately held CompareNetworks, Inc. The platform enables researchers at academic, pharmaceutical, biotech, and government labs to search, compare, and review millions of life science products, including antibodies, ELISA kits, biomolecules, flow cytometry instruments, microscopes, PCR reagents, and lab equipment, sourced from hundreds of suppliers. Core technical components include the Antibody Search Tool with multi-attribute filtering, a comprehensive product comparison database, a user-generated Product Review platform, the Flow Panel Builder, and editorial content modules (articles, bench tips, ebooks, webinars, Future Lab content hubs) spanning techniques such as Western blot, CRISPR, NGS, and cell and gene therapy. Biocompare acquired Scilan in 2022 to add AI/ML capabilities for content analysis and market intelligence.

Biocompare operates a two-sided model in which the platform is free for researchers and revenue is generated entirely from the supplier side through advertising, featured product placements, sponsored content, lead generation via quote requests, and structured market intelligence products such as the 2025 Antibody Market Report. Go-to-market is sales-led on the supplier side and content/SEO-driven on the researcher side, with topic-specific eNewsletters, social media presence, and industry event coverage as primary demand and engagement channels. The company has executed three acquisitions since 2021 (Chromocyte, Scilan, SEQanswers) to expand into flow cytometry, AI/ML, and NGS communities, and maintains GDPR and CCPA compliance under its parent CompareNetworks, Inc.

Short descriptiontext

Biocompare is a B2B product comparison and buyer education platform for life scientists, offering searchable databases, peer reviews, and editorial content across antibodies, reagents, and lab equipment, monetized through advertising, featured placements, lead generation, and market intelligence products sold to life science suppliers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science products, antibody search tool, product comparison database, scientific product reviews, lab equipment buyer guide
Product category
Life Science Product Comparison Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Advertising and Lead Generation
TypeAdvertising
Description

Biocompare generates revenue by allowing life science suppliers to advertise products and generate qualified leads from researchers using the platform. The platform connects suppliers with buyers through quote requests and product inquiries.

biocompare.com
2Featured Product Placements
TypeAdvertising
Description

Suppliers can pay for premium product placements, featured listings, and promotional placements within the platform's product categories and search results.

biocompare.com
3Content Marketing Services
TypeAdvertising
Description

Sponsored content, white papers, and editorial placements that provide market intelligence to researchers while promoting supplier products.

biocompare.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Biocompare is an online buyer's guide and product comparison platform for life scientists, providing searchable access to millions of life science products from hundreds of third-party suppliers along with peer reviews, technical articles, antibody search tools, webinars, and eNewsletters. The platform is free for researchers and monetizes through advertising, sponsored content, and lead-generation services sold to life science suppliers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Comprehensive antibody database with millions of reagents from hundreds of suppliers
+1 more record
Product overview1 text field

Biocompare is a life science product comparison and buyer education platform operated by CompareNetworks. The core offering consists of the Biocompare Antibody Search Tool and Product Comparison Database, which together enable researchers to search, compare, and review millions of life science products across categories including antibodies, ELISA kits, biomolecules, lab equipment, and molecular biology tools. The platform integrates content modules including Editorial Articles, Bench Tips, eBooks, Future Lab Content Hubs, Webinars/Videos, and Life Science News to support researcher education. A proprietary Product Reviews system allows users to submit and read peer evaluations of products. The eNewsletters service provides topic-specific email updates based on user interests. In April 2022, Biocompare acquired Scilan, an AI/ML solutions provider, to enhance data analysis and market intelligence capabilities for the life sciences sector.

Product and service6 records
1Antibody Search Tool
2Product Comparison Database
3Product Reviews
4Future Lab Content Hubs
5eNewsletters
6Scilan AI/ML Platform
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-04-06
Description

Biocompare, a division of CompareNetworks, acquired Scilan on April 6, 2022. Scilan is a provider of artificial intelligence and machine learning solutions for life science tool providers. The acquisition aims to enhance data analysis and market intelligence capabilities in the life sciences sector.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Online marketplace for new and refurbished laboratory equipment and instruments. Comparable as a B2B advertising/lead-generation platform connecting life science buyers with suppliers of lab tools.

TypeDirect peer
Description

AI-powered antibody search and selection platform serving life science researchers. Directly comparable as a digital product-discovery/advertising platform for life science reagents, with overlapping supplier-marketing monetization.

TypeDirect peer
Description

Antibody data and citation-based ranking platform used by researchers to evaluate reagent performance. Closely comparable product (antibody search/ranking) and target user (life scientists), with supplier-data monetization.

TypeDirect peer
Description

Nonprofit plasmid and reagent repository with discovery and request features serving life science researchers. Comparable as a reagent-discovery/data platform with supplier-side marketing elements, though structured as a nonprofit repository.

5Thomas Scientific
TypeDirect peer
Description

Distributor and digital catalog of laboratory supplies and equipment. Comparable as a digital channel that intermediates between life science product suppliers and research buyers, with similar catalog/search functionality.

TypeBroad incumbent
Description

Large antibody reagent supplier with its own search portal and product data portal. Comparable as a destination for antibody discovery with overlapping audience and competing with Biocompare for researcher attention, though primarily a reagent manufacturer rather than an aggregator.

TypeBroad incumbent
Description

Major antibody and reagent manufacturer with extensive educational/technical content hub. Comparable as a content-rich supplier destination competing for researcher mindshare and engagement that Biocompare also monetizes.

TypeBroad incumbent
Description

Life science trade publication and media brand delivering editorial content and supplier advertising to researchers. Comparable audience (life scientists) and revenue model (advertising/sponsored content), but editorial-led rather than product-discovery-led.

TypeBroad incumbent
Description

Large-scale laboratory supplies distributor with a digital catalog serving researchers. Comparable as a digital intermediation channel for lab product suppliers, but operates as a major distributor rather than an advertising marketplace.

TypeDirect peer
Description

Peer-review platform for laboratory products and equipment, closely analogous to Biocompare's product review system. Comparable as a researcher-driven review and product-selection platform with supplier marketing monetization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biocompare

Life Science Product Comparison Platformbiocompare.com

Biocompare is a B2B product comparison and buyer education platform for life scientists, offering searchable databases, peer reviews, and editorial content across antibodies, reagents, and lab equipment, monetized through advertising, featured placements, lead generation, and market intelligence products sold to life science suppliers.

What Biocompare does

Biocompare is a B2B product comparison and buyer education platform for the life sciences industry, operated as a division of privately held CompareNetworks, Inc. The platform enables researchers at academic, pharmaceutical, biotech, and government labs to search, compare, and review millions of life science products, including antibodies, ELISA kits, biomolecules, flow cytometry instruments, microscopes, PCR reagents, and lab equipment, sourced from hundreds of suppliers. Core technical components include the Antibody Search Tool with multi-attribute filtering, a comprehensive product comparison database, a user-generated Product Review platform, the Flow Panel Builder, and editorial content modules (articles, bench tips, ebooks, webinars, Future Lab content hubs) spanning techniques such as Western blot, CRISPR, NGS, and cell and gene therapy. Biocompare acquired Scilan in 2022 to add AI/ML capabilities for content analysis and market intelligence.

Biocompare operates a two-sided model in which the platform is free for researchers and revenue is generated entirely from the supplier side through advertising, featured product placements, sponsored content, lead generation via quote requests, and structured market intelligence products such as the 2025 Antibody Market Report. Go-to-market is sales-led on the supplier side and content/SEO-driven on the researcher side, with topic-specific eNewsletters, social media presence, and industry event coverage as primary demand and engagement channels. The company has executed three acquisitions since 2021 (Chromocyte, Scilan, SEQanswers) to expand into flow cytometry, AI/ML, and NGS communities, and maintains GDPR and CCPA compliance under its parent CompareNetworks, Inc.

Biocompare firmographics

Firmographics
Name
Biocompare
Legal name
CompareNetworks, Inc.
Website
https://biocompare.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Biocompare is a B2B product comparison and buyer education platform for life scientists, offering searchable databases, peer reviews, and editorial content across antibodies, reagents, and lab equipment, monetized through advertising, featured placements, lead generation, and market intelligence products sold to life science suppliers.
Ownership category
akta.pro rank

Where Biocompare is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Biocompare business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Advertising and Lead Generation: Biocompare generates revenue by allowing life science suppliers to advertise products and generate qualified leads from researchers using the platform. The platform connects suppliers with buyers through quote requests and product inquiries.
  2. Featured Product Placements: Suppliers can pay for premium product placements, featured listings, and promotional placements within the platform's product categories and search results.
  3. Content Marketing Services: Sponsored content, white papers, and editorial placements that provide market intelligence to researchers while promoting supplier products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Biocompare product offering

Product offering

Core offering

Biocompare is an online buyer's guide and product comparison platform for life scientists, providing searchable access to millions of life science products from hundreds of third-party suppliers along with peer reviews, technical articles, antibody search tools, webinars, and eNewsletters. The platform is free for researchers and monetizes through advertising, sponsored content, and lead-generation services sold to life science suppliers.

Product overview

Biocompare is a life science product comparison and buyer education platform operated by CompareNetworks. The core offering consists of the Biocompare Antibody Search Tool and Product Comparison Database, which together enable researchers to search, compare, and review millions of life science products across categories including antibodies, ELISA kits, biomolecules, lab equipment, and molecular biology tools. The platform integrates content modules including Editorial Articles, Bench Tips, eBooks, Future Lab Content Hubs, Webinars/Videos, and Life Science News to support researcher education. A proprietary Product Reviews system allows users to submit and read peer evaluations of products. The eNewsletters service provides topic-specific email updates based on user interests. In April 2022, Biocompare acquired Scilan, an AI/ML solutions provider, to enhance data analysis and market intelligence capabilities for the life sciences sector.

Differentiator

Problem solved

Functional benefit

Products and services

  • Antibody Search Tool
  • Product Comparison Database
  • Product Reviews
  • Future Lab Content Hubs
  • eNewsletters
  • Scilan AI/ML Platform

Quantifiable outcome

  • Comprehensive antibody database with millions of reagents from hundreds of suppliers
  • +1 more outcomes

Companies that use Biocompare

Customer profile

Segments3 records

Ideal customer profiles2 records

Biocompare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature4 records

Biocompare partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ScilancoreTechnology or Integration · 6 April 2022Biocompare, a division of CompareNetworks, acquired Scilan on April 6, 2022. Scilan is a provider of artificial intelligence and machine learning solutions for life science tool providers. The acquisition aims to enhance data analysis and market intelligence capabilities in the life sciences sector.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Biocompare competitors and assessment

Company assessment

Direct peers

  • LabX: Online marketplace for new and refurbished laboratory equipment and instruments. Comparable as a B2B advertising/lead-generation platform connecting life science buyers with suppliers of lab tools.
  • BenchSci: AI-powered antibody search and selection platform serving life science researchers. Directly comparable as a digital product-discovery/advertising platform for life science reagents, with overlapping supplier-marketing monetization.
  • CiteAb: Antibody data and citation-based ranking platform used by researchers to evaluate reagent performance. Closely comparable product (antibody search/ranking) and target user (life scientists), with supplier-data monetization.
  • Addgene: Nonprofit plasmid and reagent repository with discovery and request features serving life science researchers. Comparable as a reagent-discovery/data platform with supplier-side marketing elements, though structured as a nonprofit repository.
  • Thomas Scientific: Distributor and digital catalog of laboratory supplies and equipment. Comparable as a digital channel that intermediates between life science product suppliers and research buyers, with similar catalog/search functionality.
  • SelectScience: Peer-review platform for laboratory products and equipment, closely analogous to Biocompare's product review system. Comparable as a researcher-driven review and product-selection platform with supplier marketing monetization.

Broad incumbents

  • Abcam: Large antibody reagent supplier with its own search portal and product data portal. Comparable as a destination for antibody discovery with overlapping audience and competing with Biocompare for researcher attention, though primarily a reagent manufacturer rather than an aggregator.
  • Cell Signaling Technology: Major antibody and reagent manufacturer with extensive educational/technical content hub. Comparable as a content-rich supplier destination competing for researcher mindshare and engagement that Biocompare also monetizes.
  • The Scientist: Life science trade publication and media brand delivering editorial content and supplier advertising to researchers. Comparable audience (life scientists) and revenue model (advertising/sponsored content), but editorial-led rather than product-discovery-led.
  • Fisher Scientific: Large-scale laboratory supplies distributor with a digital catalog serving researchers. Comparable as a digital intermediation channel for lab product suppliers, but operates as a major distributor rather than an advertising marketplace.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Biocompare social profiles

Digital presence

Biocompare compliance and trust

Trust signal

Compliance2 records

Biocompare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biocompare leadership team

Management profile

Number of profiles

Profiles3 records

Biocompare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biocompare M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biocompare

What does Biocompare do?

Biocompare is an online buyer's guide and product comparison platform for life scientists, providing searchable access to millions of life science products from hundreds of third-party suppliers along with peer reviews, technical articles, antibody search tools, webinars, and eNewsletters. The platform is free for researchers and monetizes through advertising, sponsored content, and lead-generation services sold to life science suppliers.

Is Biocompare a public or private company?

Biocompare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biocompare founded?

Biocompare was founded in 1999. It employs 11 to 50 people.

Where is Biocompare based?

Biocompare is headquartered in San Francisco, United States, in the North America region.

How does Biocompare make money?

Three revenue lines are on record. Advertising and Lead Generation is the primary driver. The others are featured Product Placements and content Marketing Services.

Who are Biocompare's main competitors?

Direct peers on record are LabX, BenchSci, CiteAb, Addgene, Thomas Scientific and SelectScience. Broad incumbents are Abcam, Cell Signaling Technology, The Scientist and Fisher Scientific.

Does Biocompare have an API?

No public API is recorded for Biocompare.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTrust and Transparency Rule: How Scientists Choose Antibodies in 2025Biocompare released its 2025 Antibody Market Report based on feedback from scientists worldwide, highlighting trends in antibody selection, purchasing behavior, and usage.BiocompareAntibody Discovery to Development: Characterization as the Key to a Molecule’s FutureThis editorial from Biocompare outlines the critical role of advanced molecular characterization in transitioning antibody-based drug candidates from discovery to clinical development. The article details essential analytical techniques for verifying structural integrity, function, and stability to ensure regulatory compliance and mitigate development risks. It highlights the increasing complexity of therapies like antibody-drug conjugates (ADCs) and emphasizes collaboration with specialized contract research organizations to manage these technical demands.PrwebBiocompare, a Division of CompareNetworks, Acquires SEQanswersBiocompare, a division of CompareNetworks, has acquired SEQanswers, an online community dedicated to Next Generation Sequencing (NGS) users. The acquisition aims to provide a platform for NGS scientists to gather and exchange information in areas such as molecular diagnostics and precision medicine.PrwebBiocompare, a Division of CompareNetworks, Acquires ScilanBiocompare, a division of CompareNetworks, has acquired Scilan, a provider of artificial intelligence and machine learning solutions for life science tool providers. This acquisition aims to combine Biocompare's product information resources with Scilan's data science expertise to generate custom market intelligence for the scientific community.PrwebBiocompare Releases Documentary on "Technologies That Enable Immunotherapies"Biocompare released a four-part documentary titled "Technologies That Enable Immunotherapies," examining how analytical tools impact cancer immunotherapies. The video highlights tools for analyzing checkpoint inhibitors and CAR T-cell therapies, aiming to help researchers choose appropriate technologies.PrwebBiocompare Launches Workflow Optimization Content Hub for Life ScientistsBiocompare, with Sartorius, launched a new content hub called Future Lab: Optimizing Workflows in the Life Science Lab. The hub provides guidance on lab tools, workflow streamlining, and contamination control for life scientists. It is part of Biocompare's weekly-updated Future Lab series.PrwebBiocompare Introduces Functional Genomic Screening Content HubBiocompare launched its first 2019 content hub, Future Lab: Functional Genomic Screening, to educate researchers on FGS basics and advances. The hub covers screening libraries, CRISPR applications, gene modulation, and data analysis, and is sponsored by Horizon. It aims to engage Biocompare's 2.4 million annual visitors.PrwebBiocompare Releases Documentary on "What Researchers Need to Know about Antibody Manufacturing"Biocompare released its third documentary, "What Researchers Need to Know about Antibody Manufacturing," to educate scientists on antibody production, validation, and sourcing. The film addresses antibody validation, polyclonal antibody controversies, and shared responsibility for reproducible science. It is part of Biocompare's Reproducibility Issues in Life Science Research series.PR NewswireDocumentary on Cell Line Authentication Released by BiocompareBiocompare released a 20-minute documentary on cell line authentication, produced with international scientific leaders. The film highlights misidentified and contaminated cell lines as a cause of the reproducibility crisis, citing unreproducible results and wasted funding. It urges stakeholders to take action and calls for cell line authentication.PR NewswireBiocompare Introduces Genetic Analysis Content HubBiocompare, a life sciences information resource, launched a new content hub called 'Future Lab: Trends in Genetic Analysis' on May 23, 2018, sponsored by Thermo Fisher Scientific. The interactive hub aims to provide researchers with the latest breakthroughs, trends, news, and products in genetic analysis, covering topics such as gene expression analysis, genetic variation analysis, and disease research applications. Biocompare's Future Lab program, active since 2016, serves over 2.4 million scientists annually.